High CVD risk in patients with head, neck squamous cell cancer

High CVD risk in patients with head, neck squamous cell cancer

(HealthDay)—Twenty-three percent of patients with head and neck squamous cell carcinoma (HNSCC) have cardiovascular disease (CVD) at diagnosis, and 24 percent have uncontrolled blood pressure, according to research published online Dec. 29 in Head & Neck.

Christian C. Okoye, M.D., from Case Western Reserve University in Cleveland, and colleagues retrospectively reviewed patients with HNSCC who underwent definitive or adjuvant (chemo)radiation between 2011 and 2013. The authors calculated the 10-year risk estimates for a event according to the Framingham Risk Score (FRS).

One hundred fifteen patients with mainly stage III/IV HNSCC were followed up for a median of two years. The researchers found that 23 percent of patients had CVD at diagnosis. Patients with laryngeal cancer had higher FRS than those with cancer at other sites (20.5 versus 14.4 percent). At diagnosis, 24 percent of all patients had uncontrolled blood pressure. Forty-one and 30 percent of patients with CVD were not taking antiplatelet or statin therapy, respectively. Indications for initiating were seen for 34 percent of with CVD.

"Patients with HNSCC have a high baseline CVD risk and many do not receive optimal preventive care," the authors write.


Explore further

Periodontitis linked to HPV-positive head, neck tumors

More information: Full Text (subscription or payment may be required)

Copyright © 2017 HealthDay. All rights reserved.

Citation: High CVD risk in patients with head, neck squamous cell cancer (2017, February 2) retrieved 21 February 2020 from https://medicalxpress.com/news/2017-02-high-cvd-patients-neck-squamous.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
14 shares

Feedback to editors

User comments